Molecular Formula | C29H42F3N9O10 |
Molar Mass | 733.7 |
Storage Condition | under inert gas (nitrogen or Argon) at 2-8°C |
In vitro study | Cyclo(RGDyK) exhibits higher affinity and selectivity for αVβ3 than for αVβ5 and αiibβ3. Compared to the Cyclo(RGDyK)-free micelles (NPM), The Cyclo(RGDyK)-bound micelles (TPM) are mediated by integrin-mediated endocytosis, promotes cell-specific uptake of DiI by B16-F10 cells and HUVECs. |
In vivo study | In apoE −/− mice, Cyclo(RGDyK) (1 nmol, I. v.) inhibited the increased expression of αVβ3 integrin in the intima of the left stenotic carotid artery. |
biological activity | Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with an IC50 of 20 nM. |
Target | TargetValue αVβ3 integrin 20 nM |
Target | Value |
αVβ3 integrin | 20 nM |
In vitro studies | Cyclo(RGDyK) exhibited higher affinity and selectivity for αVβ3 than for αVβ5 and αiibβ3. Compared to the Cyclo(RGDyK)-free micelles (NPM), The Cyclo(RGDyK)-bound micelles (TPM) are mediated by integrin-mediated endocytosis, promotes cell-specific uptake of DiI by B16-F10 cells and HUVECs. |
in vivo studies | in apoE −/− mice, Cyclo(RGDyK) (1 nmol, I. v.) inhibits the increase of αVβ3 integrin expression in the intima of the left-sided stenotic carotid artery. |